Kathleen M. Jordan

FDA investigator · also recorded as Ko Kathleen M. Jordan, Ran Kathleen M. Jordan

Appears on 6 documents from 2021 to 2023, mostly at sites in Maryland. Most often cites production record review (21 CFR 211.192).

6
Documents on file
4.2
Observations per 483
2021
First seen
2023
Most recent

What they cite most

From 38 observations

Activity by year

2021: 4, 2022: 1, 2023: 1

Where

Maryland 5 · New Jersey 1

Is Kathleen M. Jordan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Modavar PharmaceuticalsJan 27, 2023 · Frederick, Maryland
483 Form 483 · FEI 3002889358Aug 25, 2022 · Branchburg, New Jersey
483 Valgene Incorporated dba Cape DrugsDec 2, 2021 · Annapolis, Maryland
483 Pharmaceutics International, Inc.Sep 29, 2021 · Cockeysville, Maryland
483 Pharmaceutics International, Inc.Sep 29, 2021 · Hunt Valley, Maryland
483 Bora Pharmaceuticals Injectables Inc.Apr 16, 2021 · Baltimore, Maryland

About this profile

What does Kathleen M. Jordan inspect?

Kathleen M. Jordan appears on 6 documents on file covering 6 sites, mostly in Maryland.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.68 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Kathleen M. Jordan is dated Jan 27, 2023.